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Abstract The Net Reclassification Improvement (NRI)
has become a popular metric for evaluating improvement
in disease prediction models through the past years. The
concept is relatively straightforward but usage and inter-
pretation has been different across studies. While no
thresholds exist for evaluating the degree of improvement,
many studies have relied solely on the significance of the
NRI estimate. However, recent studies recommend that
statistical testing with the NRI should be avoided. We
propose using confidence ellipses around the estimated
values of event and non-event NRIs which might provide
the best measure of variability around the point estimates.
Our developments are illustrated using practical examples
from EPIC-Potsdam study.
Keywords Risk assessment  Risk model  Model
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Background
Risk prediction models have become a main focus in epi-
demiological research in the past years. Although a large
number of prediction models exists, of which some have
already been integrated in treatment strategies or health
promotion programs, there is an ongoing effort to improve
prediction models by the use of new risk markers. For the
evaluation of such model extensions, the Net Reclassifi-
cation Improvement (NRI) was proposed by Pencina et al.
in 2008 as an addition to the evaluation of discrimination,
e.g. by comparing receiver operating characteristic curves
[1]. The NRI is based on the calculation of the amount of
correctly and incorrectly reclassified cases and non-cases
comparing classification of individuals into a priori defined
risk categories in terms of their predicted risk between two
nested models. Since its publication it has been used in a
growing number of studies, however, there is a large
heterogeneity in its use, presentation, and interpretation [2,
3]. Especially with regard to testing statistical significance
of NRI estimates, there remains uncertainty. Pencina [4]
discussed that even small NRI values (\0.01) might pro-
duce statistically significant p values and Pepe et al. [5]
points out that valid methods for inference for the NRI do
not exist. In a recent review of NRI measures, Kerr et al.
[2] raise concerns about the proposed test statistic and
variance formula. This suggests that statistical testing
should be avoided for the NRI measure. However, confi-
dence intervals provide precision estimates and are
preferable, not only for the overall NRI, but also for its
components. The NRI components do not reflect an overall
K. Mu¨hlenbruch (&)  O. Kuxhaus  M. B. Schulze
Department of Molecular Epidemiology, German Institute of
Human Nutrition Potsdam-Rehbruecke, Arthur-Scheunert-Allee
114-116, 14558 Nuthetal, Germany
e-mail: Kristin.Muehlenbruch@dife.de
K. Mu¨hlenbruch  O. Kuxhaus  M. B. Schulze
German Center for Diabetes Research (DZD), Nuthetal,
Germany
M. J. Pencina
Department of Biostatistics and Bioinformatics, Duke Clinical
Research Institute, Duke University, Durham, NC, USA
H. Boeing
Department of Epidemiology, German Institute of Human
Nutrition Potsdam-Rehbruecke, Nuthetal, Germany
H. Liero
Institute of Mathematics, University of Potsdam, Potsdam,
Germany
123
Eur J Epidemiol (2015) 30:299–304
DOI 10.1007/s10654-015-0001-1
improvement but rather improvement among cases and
non-cases separately. Therefore, our aim was to introduce a
method to calculate a confidence ellipse around the two
components of the NRI which reflects the precision of the
estimates and can help interpret the magnitude and vari-
ability of the observed effects.
Definition of NRI
Extension of prediction models with additional risk factors
usually leads to changes in predicted risk for individual
study participants. When predefined risk categories are
used, this is reflected by upward and downward movements
across these risk categories from the reference to the ex-
tended model. This reclassification is used for the calcu-
lation of the NRI which considers proportions of upward
and downward movements separately for cases and non-
cases (1) [1].
NRIcases ¼ P upjcaseð Þ  P downjcaseð Þ;
NRInoncases ¼ P downjnoncaseð Þ  P upjnoncaseð Þ;
NRI ¼ NRIcases þ NRInoncases
¼ P upjcaseð Þ  P downjcaseð Þ
þ P downjnoncaseð Þ  P upjnoncaseð Þ
¼ pup;cases  pdown;cases
 
þ pdown;noncases  pup;noncases
 
ð1Þ
The corresponding standard error for the NRI and its
components was defined by Pencina et al. [4] and depends






























As such, the NRI is the sum of the single components
(NRIcases, NRInon-cases) reflecting improvement among
cases or improvement among non-cases or both. Thereby,
the overall measure does not include evaluation of im-
provement among cases or non-cases separately. Absolute
risks are derived from regression models; either logistic
regression or Cox-regression with the disease as the out-
come variable.
Confidence ellipse for two components of NRI
Pencina already suggested to report CIs for the NRI and
used the bootstrap method for their construction [4]. Cal-
culation of CIs would be informative not only for the
overall NRI but also for the single components. Besides the
bootstrapping method, CIs can be calculated with a formula
related to the construction of CIs for independent propor-
tions according to Agresti [6]; this approach will be applied
further on. The standard errors for the overall NRI and its
single components were defined before, so that the CIs can











as the 1  a
2
 
-quantile of the standard normal
distribution. The CIs for NRIcases and NRInon-cases can be
calculated with the same method. While CIs of the two NRI
components, NRIcases and NRInon-cases, can be interpreted
individually, this again would not allow an easy interpre-
tation in terms of the overall improvement. To overcome
this problem, we propose to use a confidence ellipse which
allows evaluating the single components NRIcases and
NRInon-cases in combination.
We introduce the following notation: Let h ¼ ðh1;h2Þ be
the parameter consisting of the NRI components, i.e.
h1 ¼ NRIcases ¼ P upjcaseð Þ  P downjcaseð Þ and
h2 ¼ NRInoncases
¼ P downjnoncaseð Þ  P upjnoncaseð Þ
We define the following probabilities
p1 ¼ P up \ caseð Þ; p2 ¼ P down \ caseð Þ; p3
¼ P up \ noncaseð Þ; p4
¼ P down \ noncaseð Þ and p5 ¼ P caseð Þ
and can write h as a function of these probabilities:
h ¼ h1; h2ð Þ ¼ g pð Þ ¼ g1 pð Þ; g2 pð Þð Þ








Consequently, the maximum likelihood estimates of h1
and h2 are given by the relative frequencies p^j ¼ vj=N
(with N ¼ Ncases þ Nnoncases) as follows:
h^1 ¼ p^1  p^2
p^5




Case v1 v2 v5
Non-case v3 v4 N  v5
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Applying the multivariate central limit theorem to the
vector of relative frequencies p^ ¼ ðp^1; p^2; p^3; p^4; p^5ÞT we
get, that for a large sample size N the distribution ofﬃﬃﬃﬃ
N





p^  pð Þ!D N5 0; AðpÞð Þ: ð2Þ
Here AðpÞ is the covariance matrix of the limit distribution.
It depends on the underlying probabilities pj and can be
computed as:
With the help of the so-called delta method we can
derive from (2) the asymptotic variance of h^ ¼ ðh^1; h^2Þ.
Here we use, that h^ ¼ gðp^Þ. To derive the asymptotic
variance of h^ one has to multiply the matrix of partial











!D N2 0; WðpÞð Þ





w1 ¼ p1 þ p2
p25
 p1  p2ð Þ
2
p35
; w2 ¼ p3 þ p4ð1  p5Þ2




The asymptotic normality of h^ implies that
N h^ h
 T
W1 p^ð Þ h^ h
 
!D v22 ð3Þ
with v22, the Chi squared distribution with two degrees of
freedom and W1 p^ð Þ is the inverse of the matrix WðpÞ.
Because of the diagonal structure of WðpÞ and with
asymptotic result from (3) we can define a 1  að Þ confi-
dence ellipse for h as



















The determination of the confidence ellipse allows to
determine the simultaneous precision of the NRI estimates
for cases and non-cases.
Using previous notation and the following relationships
p^up;cases ¼ p^1=p^5, p^down;cases ¼ p^2=p^5, p^up;noncases ¼
p^3=ð1  p^5Þ and p^up;cases ¼ p^4=ð1  p^5Þ, the confidence el-
lipse can also be defined with the following equation.


























The European Prospective Investigation into Cancer and
Nutrition (EPIC)-Potsdam study is a prospective cohort
study initially including 27,548 participants aged
35–65 years. Details of recruitment and follow-up proce-
dures were described previously [7, 8]. Briefly, within a
median follow-up time of 7 years, 849 participants out of
25,167 participants free of diabetes at baseline developed
incident diabetes. On this basis, the German diabetes risk
score (GDRS) was developed using Cox-regression [9].
With the GDRS the 5-year risk for developing future type 2
diabetes can be calculated using information on lifestyle
and anthropometric factors, diet and physical activity. It
serves as the reference model in this underlying model
comparison. We used data from 21,846 participants (727
cases) who had also information on family history of dia-
betes available. The extended model additionally included
family history; this model was compared with the reference
model. Table 1 shows the reclassification of cases and non-
cases due to model extension based on the use of 5 pre-
defined risk categories.
Calculation of Confidence Intervals and Confidence
ellipses
Based on the asymptotic method we determined 95 % CIs
for NRIcases and NRInon-cases (Fig. 1). Taking into account
A pð Þ ¼
p1ð1  p1Þ p1p2 p1p3 p1p4 p1ð1  p5Þ
p1p2 p2ð1  p2Þ p2p3 p2p4 p2ð1  p5Þ
p1p3 p2p3 p3ð1  p3Þ p3p4 p3p5
p1p4 p2p4 p3p4 p4ð1  p4Þ p4p5
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the large number of non-cases it is obvious that estimation
of NRInon-cases was much more precise than of NRIcases. The
calculation of CIs for single components does not allow
evaluating both components in combination.
Therefore, we computed a confidence ellipse for
NRIcases and NRInon-cases to reflect precision of their esti-
mates in combination and which also allows to evaluate the
area of acceptable values. Figure 1 shows CIs for the single
components (vertical and horizontal lines) as well as the
confidence ellipse, both approaches were based on the five
risk categories described before. When constructing CIs for
the components separately, NRIcases (0.0619) has a CI of
0.0219–0.1019. Therefore, the value 0.02 lies outside of
this interval while the NRInon-cases (0.0379) had a CI
ranging from 0.0318 to 0.0440 thus including a value of
0.035. Using both CIs separately would therefore lead to
the conclusion that NRIcases is significantly higher than 0.02
while NRInon-cases is not significantly higher than 0.035.
However, examining the vector (0.02, 0.035) within the
confidence ellipse we can see that it is located inside the
area of the ellipse. Thus, the confidence ellipse indicates
that—when evaluated together—neither is the NRIcases
different from 0.02 nor is the NRInon-cases different from
0.035. This example clearly indicates that evaluating single
NRI components separately might result in different deci-
sions than evaluating the single components in combina-
tion by the use of confidence ellipses.
These results were based on the asymptotic method for
both the calculation of CIs and of the confidence ellipse.
Discussion
The use of the NRI is informative for the evaluation of
improvements of prediction models when taking into ac-
count the obvious limitations associated with the use of
categories and cut-offs. Given that no established cut-offs
for the NRI exist which allow interpreting its value as being
meaningful from a clinical or public health point of view,
reliance solely on significance testing has been frequently
adopted in reclassification analyses.
As recommended in a recent review of the NRI methods
[3], it is preferable to investigate model improvement
separately for cases or non-cases. A general framework for
testing the two components of the overall NRI, NRIcases and
NRInon-cases, has previously been laid out by Pencina et al.
[1]. However, a major drawback of examining single
components in isolation is that the results cannot be
Table 1 Reclassification table by cases and non-cases resulting from adding family history of diabetes to the German DRS (GDRS), EPIC-
Potsdam cohort (N = 21,846)
N (%) GDRS ? family history Total
1: Low 2: Still low 3: Increased 4: High 5: Very high
Cases
1: Lowa 21 (2.89) 7 (0.96) – – – 28 (3.85)
2. Still low 13 (1.79) 102 (14.03) 30 (4.13) – – 145 (19.94)
3. Increased – 32 (4.40) 176 (24.21) 61 (8.39) – 269 (37.00)
4. High – – 29 (3.99) 146 (20.08) 36 (4.95) 211 (29.02)
5. Very high – – – 15 (2.06) 59 (8.12) 74 (10.18)
Total 34 (4.68) 141 (19.39) 235 (32.32) 222 (30.54) 95 (13.07) 727 (100)
Non-cases
1. Low 9001 (42.62) 625 (2.96) – – – 9626 (45.58)
2. Still low 1415 (6.70) 4220 (19.98) 672 (3.18) – – 6307 (29.86)
3. Increased – 858 (4.06) 2613 (12.37) 387 (1.83) – 3858 (18.27)
4. High – – 269 (1.27) 782 (3.70) 98 (0.46) 1149 (5.44)
5. Very high – – – 40 (0.19) 139 (0.66) 179 (0.85)
Total 10,416 (49.32) 5703 (27.0) 3554 (16.83) 1209 (5.72) 237 (1.12) 21,119 (100)
a Risk categories were created according to score points of the German Diabetes Risk Score: low risk:\410 points (5-year risk \ 0.88 %); still
low: 410–\510 (0.88–\2.37 %); increased risk: 510–\610 (2.37–\6.30 %); high risk: 610–\710 (6.30–\16.21 %); very high risk: C710
(C16.21 %)
NRI measures were calculated as follows
NRIcases ¼ ð 0:96 þ 4:13 þ 8:39 þ 4:95ð Þ  1:79 þ 4:40 þ 3:99 þ 2:06ð ÞÞ=100 ¼ ð18:43  12:24Þ=100 ¼ 0:0619
NRInoncases ¼ ð 6:70 þ 4:06 þ 1:27 þ 0:19ð Þ  2:96 þ 3:18 þ 1:83 þ 0:46ð ÞÞ=100 ¼ ð12:22  8:43Þ=100 ¼ 0:0379
NRI ¼ 0:0619 þ 0:0379 ¼ 0:0998
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interpreted in terms of the overall model improvement. We
note that recent recommendations suggest not applying
statistical testing at all [2, 3]. Likewise, our developments
facilitate the use of confidence intervals. A particularly
appealing approach is based on using the confidence ellipse
which reflects the 2-dimensional nature of the situation.
Our empirical example indicates that confidence ellipses
can be useful in reflecting both, the precision of the NRI
estimation as well as putting the results in the context of
overall improvement.
Our proposed method of confidence ellipses is also
flexible here as it can be applied to evaluating extensions of
prediction models using equal or different weights as well
as thresholds of acceptable model improvement for cases
and non-cases as already discussed by Greenland [10].
In conclusion, confidence ellipses might be particularly
useful in the context of evaluating overall or case- versus
non-case-specific model improvement as they allow
evaluating varying acceptable values of the NRI compo-
nents in combination and also reflect the precision of their
estimates.
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